InvestorsHub Logo

rafunrafun

03/08/21 11:58 AM

#328731 RE: HDGabor #328709

Against baseline -44.9% vs -27%, against placebo -51.6% vs -33%. I leave it for professionals but - my view only - in case of TG >500, the TG reduction outweighs the risk of everything else.


I would like doctors' opinions here, please.

I think it's insane to temporarily stop treating CVD, when CVD is the #1 cause of death. Moreover, Lovaza increases LDL by 45%.